Alzheimer's Disease

SEATTLE — Sage Therapeutics will be starting a randomized, controlled trial in patients with Alzheimer’s disease, Aaron Koenig, MD, the company’s vice president of early clinical development, said at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Self-administered home use of gamma sensory stimulation reduced brain atrophy safely in people with Alzheimer’s disease, a presenter said at the 2022 American Academy of Neurology annual meeting.

Quanterix Corp. announced it has partnered with the Alzheimer’s Drug Discovery Foundation to accelerate the development of a multi-analyte plasma test for early detection of Alzheimer’s disease.

Large amounts of tau proteins in the brain affected memory function only when amyloid protein burden was also high in those with Alzheimer’s disease, data suggests in a study published in Brain.

Older adults who nap for more than an hour a day had a 40% higher risk for developing Alzheimer’s disease compared with those who napped less than an hour a day, researchers reported in Alzheimer’s & Dementia.

Neurotechnology company Cognito Therapeutics announced a partnership with Aetion to develop a validated predictive model that will help identify patients with rapidly progressing mild cognitive impairment and Alzheimer’s disease.

Increased mortality in older adults with Alzheimer’s disease and related dementias, especially in underrepresented and vulnerable populations, was closely linked to the COVID-19 pandemic, according to a study published in JAMA Neurology.

Quanterix Corp. has announced a collaboration with Eli Lilly and Co. to advance the diagnosis, monitoring and treatment of Alzheimer’s disease, according to a press release.

The FDA has given breakthrough device designation to the SOBA-AD assay, which may detect Alzheimer’s disease before symptoms arise, according to a press release.

In a company release, Roche announced a collaboration on a new phase 3 Alzheimer’s disease prevention trial, which will test an investigational subcutaneous anti-amyloid antibody.